Dr Kevin Tan | Scientific Director & Assistant Professor
Biolynx Technologies & National University of Singapore

Dr. Kevin Tan pursued his PhD at the Department of Microbiology NUS and his postdoctoral studies at the Laboratory of Molecular Parasitology, The Rockefeller University, New York, under the supervision of Professor George Cross. Upon his return to Singapore in 2003, he began his research on protozoan cell death focusing on PCD pathways in the enteric parasite Blastocystis and the malaria parasite Plasmodium falciparum. His research involves understanding the molecular mechanisms of protozoan PCD and translating that knowledge to accelerate drug discovery. Kevin is the founding Director of BioLynx Technologies, an NUS spin-out company focusing on the commercialization of fluorescent-tagged drugs for research and diagnosis.